Benchmark raised the firm’s price target on Omnicell (OMCL) to $60 from $50 and keeps a Buy rating on the shares ahead of the company reporting its 2026 results on Thursday. The firm continues to believe Omnicell is positioned to guide FY26 ahead of consensus models, which are little changed since the Q3 results, the analyst tells investors in a preview.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell: Gradual Fundamental Improvement but Balanced Risk/Reward Supports Neutral (Hold) Rating
- KeyBanc upgrades Omnicell to Overweight ahead of ‘super-cycle’
- Omnicell upgraded to Overweight from Sector Weight at KeyBanc
- Omnicell price target raised to $52 from $43 at Wells Fargo
- Omnicell: Anticipated Tariff Relief, Policy Tailwinds, and Booking Inflection Support Buy Rating and Re-Rating Potential